Most Americans Unaware of Excessive Weight as a Risk for Some Cancers

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 10
Volume 11
Issue 10

WASHINGTON-Most Americans worry about developing cancer and being overweight, but few of them recognize that excessive pounds are a risk factor for some common cancers, according to a new survey commissioned by the American Institute for Cancer Research (AICR). Of those polled, 61% said they were either very or somewhat concerned about receiving a diagnosis of cancer. Yet when asked to name major risk factors for cancer other than smoking, only 6% listed overweight or obesity.

WASHINGTON—Most Americans worry about developing cancer and being overweight, but few of them recognize that excessive pounds are a risk factor for some common cancers, according to a new survey commissioned by the American Institute for Cancer Research (AICR). Of those polled, 61% said they were either very or somewhat concerned about receiving a diagnosis of cancer. Yet when asked to name major risk factors for cancer other than smoking, only 6% listed overweight or obesity.

A recent review of the scientific literature by AICR found that excessive weight increased the risk of six types of malignancies—postmenopausal breast, colon, endometrial, esophageal, prostate, and kidney—by 25% to 33%.

In the survey, conducted by the polling firm Harris Interactive, only 14% said they were not concerned at all about getting cancer and 24% said they were not very concerned. A significantly greater percentage of Americans earning less than $15,000 expressed concern about developing the disease than those earning higher incomes—35% vs 20%. And 73% of blacks said they were very or somewhat concerned vs 60% of whites. Women are more concerned than men: While 41% of the men said they were not worried about cancer, only 34% of the women expressed no concern.

When asked about cancer risk factors other than smoking, survey respondents mentioned certain chemicals (22%), overexposure to the sun (18%), consuming a high-fat diet (18%), heavy alcohol use (7%), and excessive weight (6%).

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content